Localization of myosin II regulatory light chain in the cerebral vasculature

Jane E Ishmael1, Christiane V Löhr, Kay Fischer

  • 1Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, OR 97331, USA. jane.ishmael@oregonstate.edu

Acta Histochemica
|October 27, 2007
PubMed

Insights

Myosin II RLC is present in mouse brain blood vessels, impacting blood-brain barrier (BBB) function. Its distribution suggests a role in BBB integrity and brain vulnerability.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Vascular Biology

Background:

  • The blood-brain barrier (BBB) is crucial for brain function and its integrity is regulated by the endothelial cytoskeleton.
  • Myosin II regulatory light chain (RLC) phosphorylation state influences BBB integrity, with implications in alcohol abuse, hypoxia, and statin drug effects.

Purpose of the Study:

  • To investigate the distribution of myosin II RLC in the cerebral vasculature of mice.
  • To understand the role of myosin II RLC in the actomyosin cytoskeleton of cerebral endothelial cells.

Main Methods:

  • Immunohistochemistry was used to visualize myosin II RLC distribution.
  • Light microscopy was employed to examine immunolocalization in brain capillaries, arterioles, and venules.

Main Results:

  • Myosin II RLC was found widely distributed throughout the cerebral vasculature.
  • Immunolocalization confirmed myosin II RLC presence in the endothelium of capillaries, arterioles, and venules.
  • Distinction was made between endothelial and smooth muscle myosin II RLC.

Conclusions:

  • Myosin II RLC is a component of the actomyosin cytoskeleton in cerebral endothelial cells.
  • Myosin II RLC has the potential to influence the selective vulnerability of the brain.
  • These findings highlight myosin II RLC as a key player in BBB regulation.